24.03.2013 Views

Thyroid Hormone in 7,12-Dimethylbenz(a ... - Cancer Research

Thyroid Hormone in 7,12-Dimethylbenz(a ... - Cancer Research

Thyroid Hormone in 7,12-Dimethylbenz(a ... - Cancer Research

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Thyroid</strong> <strong>Hormone</strong> <strong>in</strong> 7,<strong>12</strong>-<strong>Dimethylbenz</strong>(a)anthracene-<strong>in</strong>duced<br />

Leukemia <strong>in</strong> Rats<br />

Alan K. Burnett<br />

<strong>Cancer</strong> Res 1979;39:4252-4255.<br />

Updated version<br />

Access the most recent version of this article at:<br />

http://cancerres.aacrjournals.org/content/39/10/4252<br />

E-mail alerts Sign up to receive free email-alerts related to this article or journal.<br />

Repr<strong>in</strong>ts and<br />

Subscriptions<br />

Permissions<br />

To order repr<strong>in</strong>ts of this article or to subscribe to the journal, contact the AACR Publications<br />

Department at pubs@aacr.org.<br />

To request permission to re-use all or part of this article, contact the AACR Publications<br />

Department at permissions@aacr.org.<br />

Downloaded from<br />

cancerres.aacrjournals.org on March 23, 2013. © 1979 American Association for <strong>Cancer</strong> <strong>Research</strong>.


[CANCER RESEARCH 39. 4252-4255, October 1979)<br />

0008-5472/79/0039-OOOOS02 00<br />

<strong>Thyroid</strong> <strong>Hormone</strong> <strong>in</strong> 7,<strong>12</strong>-<strong>Dimethylbenz</strong>(a)anthracene-<strong>in</strong>duced Leukemia <strong>in</strong><br />

Rats1<br />

Alan K. Burnett2<br />

The Ben May Laboratory for <strong>Cancer</strong> <strong>Research</strong>. University of Chicago, Chicago. Ill<strong>in</strong>ois 60637<br />

ABSTRACT<br />

<strong>Thyroid</strong>ectomy reduces the <strong>in</strong>cidence of hormone-depend<br />

ent stem cell leukemia elicited by 4 biweekly doses of 7,<strong>12</strong>dimethylbenz(a)anthracene<br />

to Long-Evans rats (22% com<br />

pared with 46% <strong>in</strong> control animals). There is a high <strong>in</strong>cidence<br />

of early death due to aplastic anemia <strong>in</strong> the thyroidectomized<br />

rats (70%) compared with controls (34%). In established leu<br />

kemia, neither thyroidectomy nor thyrox<strong>in</strong>e excess produces<br />

any last<strong>in</strong>g benefit. In all experiments, the thyroid status of<br />

each rat is cont<strong>in</strong>uously measured by the free thyrox<strong>in</strong>e <strong>in</strong>dex.<br />

INTRODUCTION<br />

A stem cell leukemia can be <strong>in</strong>duced rapidly by a series of<br />

P.O. feed<strong>in</strong>gs of DMBA3 to Long-Evans rats (8). A remarkable<br />

feature of this leukemia is its rapid regression follow<strong>in</strong>g hypo-<br />

physectomy <strong>in</strong> substantial numbers of rats with primary leuke<br />

mia or bear<strong>in</strong>g transplants of leukemia cells (7,11,19).<br />

Which s<strong>in</strong>gle hormone or comb<strong>in</strong>ation of hormones under<br />

pituitary control is responsible for this effect is not known.<br />

Prolact<strong>in</strong> has been found to be unimportant <strong>in</strong> the <strong>in</strong>duction<br />

time and <strong>in</strong>cidence of this leukemia (1, 20).<br />

The activity of the thyroid gland is under trophic <strong>in</strong>fluence of<br />

the pituitary and it is now well established that thyroid hormone<br />

markedly affects the oxidative metabolism of cells (3). Thus, it<br />

seems possible that <strong>in</strong>terference with thyroid gland activity may<br />

be responsible for the pituitary ablative effect on leukemic cell<br />

growth. Previous <strong>in</strong>vestigations of the role of the thyroid <strong>in</strong> the<br />

development and growth of tumors have been sporadic, and<br />

the results have been conflict<strong>in</strong>g. On one hand, some workers<br />

(4, 6, <strong>12</strong>, 13, 15, 21 ) found that alteration <strong>in</strong> the thyroid status<br />

<strong>in</strong>fluenced the <strong>in</strong>duction and rate of growth of a variety of<br />

tumors <strong>in</strong>clud<strong>in</strong>g leukemias, whereas others (14, 18) could<br />

demonstrate little <strong>in</strong>fluence of thyroid hormone on tumor<br />

growth.<br />

In none of these studies, however, was the thyroid status<br />

monitored dur<strong>in</strong>g the period when altered hormone levels were<br />

assumed to be present. This paper, therefore, represents the<br />

first controlled study of the <strong>in</strong>fluence of thyroid activity on the<br />

<strong>in</strong>duction and ma<strong>in</strong>tenance of a hydrocarbon-<strong>in</strong>duced leukemia<br />

where hormone levels have been carefully monitored through<br />

out the period of experimental observation.<br />

MATERIALS AND METHODS<br />

Animals. Long-Evans rats were studied exclusively. They<br />

' Supported pr<strong>in</strong>cipally by grants from the American <strong>Cancer</strong> Society and the<br />

Jane Coff<strong>in</strong>s Childs Memorial Fund for Medical <strong>Research</strong>, by USPHS <strong>Research</strong><br />

Grant CA 11603 from the National <strong>Cancer</strong> Institute, and laterally by The Leukemia<br />

<strong>Research</strong> Fund<br />

' Present address: Department of Haematology, Glasgow Royal Infirmary,<br />

Glasgow, G4 OSF. Scotland.<br />

' The abbreviation used is: DMBA, 7.<strong>12</strong>-dimethylbenz(a)anthracene.<br />

Received May 25. 1976; accepted July 19, 1979<br />

were taken from a random-bred closed colony of rats which<br />

has been ma<strong>in</strong>ta<strong>in</strong>ed for 14 years. The rats were housed <strong>in</strong><br />

sta<strong>in</strong>less steel or plastic cages <strong>in</strong> air-conditioned rooms at 25<br />

±1°(S.D.), artificially lit for <strong>12</strong> hr/day. They were fed com<br />

mercial ration [Rockland Mouse/Rat diet (Teklad, Monmouth,<br />

III.) or Diet 41 (William Shearer Ltd., Glasgow, Scotland)]. Tap<br />

water was given freely. Ether was used as anesthetic when<br />

required. Vag<strong>in</strong>al smears were exam<strong>in</strong>ed daily.<br />

Induction of Leukemia. In experiments to assess the effect<br />

of thyroidectomy on the <strong>in</strong>duction of leukemia, a 15% (w/v)<br />

emulsion of DMBA (k<strong>in</strong>dly supplied by Dr. Paul Schurr, The<br />

Upjohn Company, Kalamazoo, Mich.) was <strong>in</strong>jected <strong>in</strong>to the tail<br />

ve<strong>in</strong> of 44- to 54-day-old rats (designated Day 0). This was<br />

repeated on a further 3 occasions at 14-day <strong>in</strong>tervals; the dose<br />

was fixed at 30 mg/kg body weight. In experiments on estab<br />

lished leukemia, the leukemia was <strong>in</strong>duced by p.o. adm<strong>in</strong>istra<br />

tion of a solution of ref<strong>in</strong>ed 0.5% (w/v) DMBA <strong>in</strong> sesame oil, as<br />

described previously (11), to animals ages 28 to 35 days <strong>in</strong> a<br />

dose of 175 mg/kg body weight, and on 3 further occasions<br />

at 14-day <strong>in</strong>tervals <strong>in</strong> a dose of 10 mg to each rat.<br />

Diagnosis of Leukemia. The most convenient method of<br />

early diagnosis of this leukemia is its appearance on open liver<br />

biopsy as described earlier (8). The first diagnostic liver biopsy<br />

was performed 14 days after the f<strong>in</strong>al exposure to carc<strong>in</strong>ogen<br />

(i.e., Day 56), and on a further 7 occasions at 14-day <strong>in</strong>tervals<br />

thereafter.<br />

Hematological Studies. Blood for hematological procedures<br />

was obta<strong>in</strong>ed by cardiac puncture <strong>in</strong>to a hepar<strong>in</strong>ized syr<strong>in</strong>ge<br />

and exam<strong>in</strong>ed by conventional hematological techniques.<br />

Erythropoiesis was estimated by 59Fe uptake <strong>in</strong>to bone marrow<br />

2 hr after <strong>in</strong>jection of a dose of 1 juCi/g body weight (17).<br />

<strong>Thyroid</strong>ectomy. Thyroparathyroidectomy was performed by<br />

surgical avulsion. In <strong>in</strong>duction experiments, this preceded the<br />

first dose of carc<strong>in</strong>ogen by 6 to 7 days <strong>in</strong> all cases. All<br />

thyroparathyroidectomized rats were given 1% calcium lactate<br />

<strong>in</strong> the dr<strong>in</strong>k<strong>in</strong>g water to avoid tetany. Completeness of thyroid<br />

ectomy was assessed by assay of the free thyrox<strong>in</strong>e <strong>in</strong>dex.<br />

This <strong>in</strong>dex is derived from multiply<strong>in</strong>g the product of the free<br />

thyrox<strong>in</strong>e level (jug/100 ml), based on a competitive b<strong>in</strong>d<strong>in</strong>g<br />

technique (16), and the ratio of the uptake of thyrox<strong>in</strong>e onto<br />

res<strong>in</strong> beads compared with standard sera. Serum from all<br />

animals was assessed at approximately 6 weekly <strong>in</strong>tervals.<br />

Assay of 85 normal rats established a normal range of 5.46<br />

± 1.46 (S.D.). <strong>Thyroid</strong>ectomy was considered <strong>in</strong>complete if<br />

the free thyrox<strong>in</strong>e <strong>in</strong>dex was greater than 1.0. L-Thyrox<strong>in</strong>e<br />

(Sigma Chemical Co., St. Louis, Mo.) was adm<strong>in</strong>istered <strong>in</strong> a<br />

dose of 10 fig/day s.c.<br />

RESULTS<br />

Anatomical and Hematological Effects of <strong>Thyroid</strong>ectomy.<br />

Female rats were used for this study. <strong>Thyroid</strong>ectomy was<br />

performed at age 21 days. The animals became sluggish,<br />

4252 CANCER RESEARCH VOL. 39<br />

Downloaded from<br />

cancerres.aacrjournals.org on March 23, 2013. © 1979 American Association for <strong>Cancer</strong> <strong>Research</strong>.


developed coarse fur, and showed retardation of body growth<br />

(Chart 1). Open<strong>in</strong>g of the vag<strong>in</strong>al plate was not delayed, and<br />

periodicity of the estrus cycle was normal. A mild nonprogres<br />

sive anemia developed around the 35th postthyroidectomy<br />

day. No persistent significant differences <strong>in</strong> peripheral WBC or<br />

platelet count were noted. At the 77th postthyroidectomy day,<br />

a small but significant reduction (p < 0.05) <strong>in</strong> spleen size was<br />

observed: 0.18 ± 0.02 versus 0.21 ± 0.01 g/100 g body<br />

weight (10 rats <strong>in</strong> each group).<br />

Erythropoiesis as measured by 59Fe <strong>in</strong>corporation <strong>in</strong>to bone<br />

marrow 77 days postthyroidectomy was significantly reduced<br />

( p < 0.05) <strong>in</strong> the thyroidectomized group (1148 ±324 versus<br />

1773 ±402 cpm, wet weight, bone marrow; 8 rats <strong>in</strong> each<br />

group).<br />

The Effect of <strong>Thyroid</strong>ectomy on Induction of Leukemia. In<br />

the series of experiments to assess the effect of hypothyroidism<br />

on the <strong>in</strong>duction of leukemia, 21 7 adequately thyroidectomized<br />

rats and 138 <strong>in</strong>tact littermates were given 4 doses of carc<strong>in</strong>o<br />

gen at biweekly <strong>in</strong>tervals. Two major effects were noted.<br />

First, there was a significantly higher <strong>in</strong>cidence of early death<br />

<strong>in</strong> the thyroidectomized group, compared with controls. Only<br />

45 of the orig<strong>in</strong>al 219 thyroidectomized animals became "ef<br />

fective," i.e., survived until the day of the first diagnostic liver<br />

biopsy (Day 56), compared with 90 of 138 controls (p <<br />

0.001).<br />

The majority of deaths occurred follow<strong>in</strong>g the second or third<br />

<strong>in</strong>jection of carc<strong>in</strong>ogen and appeared to be due, <strong>in</strong> the majority<br />

of cases, to aplastic anemia. This was characterized by loss of<br />

body weight, loss of normal estrus periodicity <strong>in</strong> females,<br />

reduced body temperature, peripheral blood pancytopenia,<br />

and marrow hypoplasia or aplasia.<br />

Second, of the 45 "effective" thyroidectomized animals, 10<br />

42<br />

49<br />

3»<br />

36<br />

34<br />

32<br />

30<br />

28<br />

Hematocrit Platelets<br />

/ *<br />

7 14 21 28 35 42 49 56 63 70 77<br />

day «•<br />

13,000+ Leukocytes<br />

7 14 21 28 35 42 49 56<br />

j<br />

<strong>Thyroid</strong> <strong>Hormone</strong> In <strong>Hormone</strong>-dependent Leukemia<br />

(22%) developed leukemia by Day 140 compared with 41<br />

(46%) of the 90 "effective" controls (p < 0.01) (Table 1).<br />

S<strong>in</strong>ce several animals from each group succumbed to the<br />

stress of repeated diagnostic liver biopsy, the <strong>in</strong>cidence of<br />

leukemia was assessed on each biopsy day (Table 1). There<br />

was a statistically significant difference (p < 0.05) on Day 56,<br />

but on each other day the differences failed to achieve signifi<br />

cance. However, the total number of rats develop<strong>in</strong>g leukemia<br />

by Days 56, 70, 84, 98, and 1<strong>12</strong> was significantly greater <strong>in</strong><br />

controls compared with thyroidectomized rats (Day 56, p <<br />

0.06; Day 70, p < 0.05; Day 84, p < 0.01 ; Day 98, p < 0.05,<br />

Day 1<strong>12</strong>, p < 0.01).<br />

There were no significant differences <strong>in</strong> the time taken to<br />

develop leukemia between the groups (thyroidectomy, 91 ±<br />

29 days; controls, 78 ±26 days). The statistical test used <strong>in</strong><br />

these experiments was x? with Yates correction for small num<br />

bers.<br />

Effect of <strong>Thyroid</strong>ectomy on Stem Cell Leukemia. None of<br />

the animals with established primary leukemia which were<br />

subjected to thyroidectomy showed any reduction <strong>in</strong> growth of<br />

leukemia. In every case, peripheral blood values deteriorated,<br />

and liver biopsy on the 14th postoperative day exhibited more<br />

extensive <strong>in</strong>filtration than preoperatively (Table 2). Survival <strong>in</strong><br />

the thyroidectomized animals was shorter (21 ±9.9 days) than<br />

<strong>in</strong> controls (29.4 ±14.0 days).<br />

Effect of Thyrox<strong>in</strong>e Excess on Stem Cell Leukemia. Of the<br />

20 animals with primary leukemia that received large doses of<br />

thyrox<strong>in</strong>e, 18 showed clear deterioration (Table 3). Peripheral<br />

blood values had deteriorated, and liver histology exhibited<br />

marked deterioration. Two animals, however, showed improve<br />

ment <strong>in</strong> peripheral blood <strong>in</strong>dices. In these cases, liver biopsy<br />

showed apparent complete regression <strong>in</strong> one, and partial<br />

28 35 42 49 56 63 70 77<br />

7 14 21 28 35 42 49 56 63 70 77<br />

Chart 1. The effect of thyroidectomy on peripheral blood and body weight. <strong>Thyroid</strong>ectomy performed at 21 days of age (Day 0). Each po<strong>in</strong>t is the mean of 8<br />

nalpK<br />

females<br />

OCTOBER 1979 4253<br />

Downloaded from<br />

cancerres.aacrjournals.org on March 23, 2013. © 1979 American Association for <strong>Cancer</strong> <strong>Research</strong>.


A. K. Burnett<br />

Table 1<br />

Ellect of thyroidectomy on <strong>in</strong>duction ol stem cell leukemia<br />

<strong>Thyroid</strong>eclomized rats were given DMBA, 30 mg/kg, on 4 occasions at 14-day <strong>in</strong>tervals commenc<strong>in</strong>g at age 44 to<br />

54 days Rats surviv<strong>in</strong>g until the first diagnostic liver biopsy (Day 56) are termed effective" rats<br />

<strong>Thyroid</strong>ectomy<br />

ControlInitial<br />

1/13ap


The metabolism of DMBA may be retarded <strong>in</strong> thyroidecto-<br />

mized animals, permitt<strong>in</strong>g its toxic effects on the bone marrow<br />

to be enhanced. Hypothyroidism is known to <strong>in</strong>hibit hepatic<br />

pyrid<strong>in</strong>e nucleotide-l<strong>in</strong>ked dehydrogenases (10). Adm<strong>in</strong>istra<br />

tion of DMBA causes an <strong>in</strong>crease <strong>in</strong> hepatic menadione reductase<br />

(9). Our <strong>in</strong>itial experiments, however, <strong>in</strong>dicate that the<br />

<strong>in</strong>crease <strong>in</strong> the hepatic level of this enzyme follow<strong>in</strong>g adm<strong>in</strong>is<br />

tration of carc<strong>in</strong>ogen is no different <strong>in</strong> hypothyroid animals.<br />

Investigation of this aspect cont<strong>in</strong>ues.<br />

ACKNOWLEDGMENTS<br />

The author is deeply <strong>in</strong>debted to Dr. Charles Mugg<strong>in</strong>s of the Ben May<br />

Laboratory. University of Chicago, for his k<strong>in</strong>dness and encouragement with this<br />

work. He also wishes to thank Dr. Leslie De Groot, The <strong>Thyroid</strong> Study Group.<br />

University of Chicago, and Wendy Radcliffe. Department of Biochemistry. Glas<br />

gow Royal Infirmary, Scotland, for facilities to measure thyroid status.<br />

REFERENCES<br />

1. Aida, M. The effect of pituitary hormones on 7.1 2-dimethylbenz(a)anthracene-<strong>in</strong>duced<br />

rat leukemia. Wakayama Med. Rep.. Ã6.57-76. 1974<br />

2. Bird. C. C. Leukemia <strong>in</strong>duced by 7.8.<strong>12</strong>-trimethylbenz(a)anthracene <strong>in</strong> rats.<br />

II. Changes <strong>in</strong> Bone Marrow. J. Nati. <strong>Cancer</strong> Inst., 48: 429-439. 1972.<br />

3. Burgi, H., and Labhart. A. In: A. Labhart (ed.). The <strong>Thyroid</strong> Gland, Spr<strong>in</strong>ger-<br />

Verlag, pp. 135-283. New York: 1974.<br />

4. Dargent, M., Viallier, J.. and Gu<strong>in</strong>et. E. Influence de la secretion thyroïdienne<br />

sur la Croissance des tumeurs. Ann. Inst. Pasteur (Paris), 8J. 357-361,<br />

1951.<br />

5. Ford, E., and Mugg<strong>in</strong>s, C. Selective destruction <strong>in</strong> testis <strong>in</strong>duced by 7,<strong>12</strong>dimethylbenz(a)anthracene.<br />

J. Exp. Med.. 118: 27-40. 1963.<br />

6. Grad, B., Oberleitner. A., and Berenson. J. The effect of thyrox<strong>in</strong>e and<br />

thiouracil on thé<strong>in</strong>cidence of lymphogenous leukemia <strong>in</strong> AKR mice. Proc.<br />

Am. Assoc. <strong>Cancer</strong> Res.. J. 20-21. 1953.<br />

7. Hugg<strong>in</strong>s, C. B., and Oka, H. Regression of stem-cell erythroblastic leukemia<br />

Thyro/d <strong>Hormone</strong> In <strong>Hormone</strong>-dependent Leukemia<br />

after hypophysectomy. <strong>Cancer</strong> Res.. 32 239-242. 1972.<br />

8. Hugg<strong>in</strong>s, C. B., and Sugiyama, T. Induction of leukemia <strong>in</strong> rat by pulse doses<br />

of 7,<strong>12</strong>-dimethylbenz(a)anthracene. Proc. Nati. Acad. Sei. U. S. A., 55: 74-<br />

81, 1966.<br />

9. Hugg<strong>in</strong>s, C. B.. Ueda, N., and Russo, A. Azo dyes prevent hydrocarbon<strong>in</strong>duced<br />

leukemia <strong>in</strong> the rat Proc. Nati. Acad. Sei. U. S. A.. 75 4524-4527,<br />

1978.<br />

10. Hugg<strong>in</strong>s, C., and Yao. F-O. Influence of hormones on liver. 1. Effects of<br />

steroids and thyrox<strong>in</strong>e on pryid<strong>in</strong>e nucleotide-l<strong>in</strong>ked dehydrogenases. J.<br />

Exp. Med.. ; 10: 899-919, 1959.<br />

11. Hugg<strong>in</strong>s. C. B., Yoshida, H.. and Bird, C. C. <strong>Hormone</strong>-dependent stem-cell<br />

leukemia evoked by a series of feed<strong>in</strong>gs of 7,<strong>12</strong>-dimethylbenz(a)anthracene<br />

J. Nati. <strong>Cancer</strong> Inst., 52. 1301-1305. 1974.<br />

<strong>12</strong>. Juli, J. W., and Hugg<strong>in</strong>s, C. B. Influence of hyperthyroidism and of thyroidectomy<br />

on <strong>in</strong>duced mammary cancer. Nature (Lond.), 188: 73. 1960.<br />

13. Kreyberg, L. The <strong>in</strong>fluence of <strong>in</strong>tr<strong>in</strong>sic factors on the development of <strong>in</strong>duced<br />

tumors <strong>in</strong> animals. Acta Pathol. Microbiol. Scand. Suppl., 37; 317-338,<br />

1938<br />

14. Morimota, S. Influence of thyroidectomy on tar-epithelioma Acta Dermatol.<br />

Kyoto (Engl. Ed.), )9. 185-186, 1932.<br />

15. Morris. D. M.. Upton, C. A., and Wolf, F. F. The <strong>in</strong>fluence of the thyroid<br />

gland on the susceptibility of AKR mice to transplanted lymphoid leukemia.<br />

Proc. Am. Assoc. <strong>Cancer</strong> Res.. 2 36, 1955.<br />

16. Murphy, B. P.. and Jachan, C. The determ<strong>in</strong>ation of thyrox<strong>in</strong>e by competitive<br />

prote<strong>in</strong>-b<strong>in</strong>d<strong>in</strong>g analysis employ<strong>in</strong>g an anion-exchange res<strong>in</strong> and radiothyrox<strong>in</strong>e.<br />

J. Lab. Cl<strong>in</strong>. Med.. 66. 161-167, 1965.<br />

17. Reddi, A. H.. and Hugg<strong>in</strong>s. C. B. Formation of bone marrow <strong>in</strong> fibroblasttransformation<br />

ossicles. Proc. Nati. Acad. Sei. U. S. A., 72 22<strong>12</strong>-2216.<br />

1975.<br />

18. Solviter, H. A. The effect of complete ablation of thyroid tissue by radioactive<br />

iod<strong>in</strong>e on the survival of tumor-bear<strong>in</strong>g mice. <strong>Cancer</strong> Res.. ) /. 447-449,<br />

1951.<br />

19. Ueda, N., and Hugg<strong>in</strong>s, C B. Regression of experimental leukemias follow<strong>in</strong>g<br />

hypophysectomy. Proc Am. Assoc. <strong>Cancer</strong> Res , 16 13, 1975.<br />

20. Welsch. C. W.. Horowitz. S., and Hugg<strong>in</strong>s. C. B. Influence of prolact<strong>in</strong> on<br />

carc<strong>in</strong>ogen-<strong>in</strong>duced leukemagenesis <strong>in</strong> Long-Evans rats. <strong>Cancer</strong> Res., 35:<br />

3746-3749. 1975.<br />

21. Wolfson. S. L., Drake, J., and Bass. A. D. Effect of athyreosis on the<br />

<strong>in</strong>duction of rat sarcoma with 3-methylcholanthracene. Growth. 20. 19-28,<br />

OCTOBER 1979 4255<br />

Downloaded from<br />

cancerres.aacrjournals.org on March 23, 2013. © 1979 American Association for <strong>Cancer</strong> <strong>Research</strong>.<br />

1956.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!